Literature DB >> 21626373

[Legionella pneumophila : genetic diversity of patients and environmental isolates].

C Lück1.   

Abstract

Legionellae are environmental bacteria that can be frequently isolated from technical water supply systems. The most prevalent species is Legionella pneumophila, especially serogroup 1. In the environment, legionellae multiply in amoebae. Since Legionella pneumonias cannot be distinguished from pneumonias caused by other microbial pathogens, special microbiological tests, e.g., urinary antigen assays, are essential to detect Legionella infections. All water supply systems to which the patient is exposed during the incubation time of 2 to 10 days might be the source of the infection. This can be confirmed or excluded by molecular typing of isolates from patients and the environment. The most commonly used techniques are monoclonal antibody typing and sequence-based typing (SBT). Some sequence types (ST) are frequently found among clinical strains but are seldom isolated from the environment, e.g., ST 23, 42, 47, 62, and 146. It is safe to assume that such strains are highly virulent. Conversely, it does not seem to be justified to dedicate the same awareness to all environmental Legionella strains.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21626373     DOI: 10.1007/s00103-011-1282-5

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  2 in total

1.  Epidemiologic characteristics associated with ST23 clones compared to ST1 and ST47 clones of Legionnaires disease cases in France.

Authors:  P Cassier; C Campese; Y Le Strat; D Che; C Ginevra; J Etienne; S Jarraud
Journal:  New Microbes New Infect       Date:  2014-11-12

2.  Source attribution of community-acquired cases of Legionnaires' disease-results from the German LeTriWa study; Berlin, 2016-2019.

Authors:  Udo Buchholz; Heiko Juergen Jahn; Bonita Brodhun; Ann-Sophie Lehfeld; Marina M Lewandowsky; Franziska Reber; Kristin Adler; Jacqueline Bochmann; Christina Förster; Madlen Koch; Yvonne Schreiner; Fabian Stemmler; Corinna Gagell; Edith Harbich; Sina Bärwolff; Andreas Beyer; Ute Geuß-Fosu; Martina Hänel; Patrick Larscheid; Lukas Murajda; Klaus Morawski; Uwe Peters; Raimund Pitzing; Andreas von Welczeck; Gudrun Widders; Nicoletta Wischnewski; Inas Abdelgawad; Anke Hinzmann; Denis Hedeler; Birte Schilling; Silvia Schmidt; Jakob Schumacher; Irina Zuschneid; Iskandar Atmowihardjo; Keikawus Arastéh; Steffen Behrens; Petra Creutz; Johannes Elias; Martina Gregor; Stefan Kahl; Henning Kahnert; Viktor Kimmel; Josefa Lehmke; Pascal Migaud; Agata Mikolajewska; Verena Moos; Maria-Barbara Naumann; Wulf Pankow; Hans Scherübl; Bernd Schmidt; Thomas Schneider; Hartmut Stocker; Norbert Suttorp; Dorina Thiemig; Carsten Gollnisch; Uwe Mannschatz; Walter Haas; Benedikt Schaefer; Christian Lück
Journal:  PLoS One       Date:  2020-11-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.